hydrazine has been researched along with Bone Marrow Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, C; Kong, D; Li, Y; Tian, H; Wang, Z; Wu, D; Yin, J; Yu, Z | 1 |
| Al-Samkari, H; Park, AK; Park, JC | 1 |
| Kuter, DJ; Makar, RS; Sahud, MA; Zhukov, OS | 1 |
| Kulasekararaj, AG; Marsh, JC | 1 |
| Chaimani, A; Desborough, M; Doree, C; Estcourt, LJ; Hadjinicolaou, AV; Hopewell, S; Stanworth, SJ; Trivella, M; Vyas, P | 1 |
| Sekeres, MA | 1 |
| Cela, I; Katz, RS; Miller, IJ; Rizman, A; Shammo, JM | 1 |
| Bosworth, J; Lown, R; Rhodes, E; Shannon, MS; Stasi, R | 1 |
| Arning, M; Bailey, CK; Brainsky, A; Bussel, JB; Cheng, G; Meyer, O; Saleh, MN | 1 |
| BOLLAG, W; D ALESSANDRI, A; KEEL, HJ; MARTZ, G | 1 |
| Nixon, DD; Ultmann, JE | 1 |
5 review(s) available for hydrazine and Bone Marrow Diseases
| Article | Year |
|---|---|
Management of the refractory aplastic anemia patient: what are the options?
Topics: Adult; Age Factors; Alemtuzumab; Allografts; Anemia, Aplastic; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Antineoplastic Agents; Benzoates; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Hydrazines; Immunosuppression Therapy; Immunosuppressive Agents; Middle Aged; Pyrazoles; Siblings; Survival Rate; Unrelated Donors | 2013 |
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.
Topics: Benzoates; Bone Marrow Diseases; Chronic Disease; Deamino Arginine Vasopressin; Hemorrhage; Hemostatics; Humans; Hydrazines; Platelet Transfusion; Pyrazoles; Randomized Controlled Trials as Topic; Receptors, Fc; Recombinant Fusion Proteins; Thrombocytopenia; Thrombopoietin; Tranexamic Acid | 2016 |
Treatment of MDS: something old, something new, something borrowed...
Topics: Azacitidine; Benzoates; Blood Transfusion; Bone Marrow Diseases; Chromosome Deletion; Chromosomes, Human, Pair 5; Clinical Trials as Topic; Combined Modality Therapy; Decitabine; DNA-Cytosine Methylases; Glutathione; Hematinics; Humans; Hydrazines; Immunologic Factors; Lenalidomide; Myelodysplastic Syndromes; Pyrazoles; Randomized Controlled Trials as Topic; Receptors, Fc; Recombinant Fusion Proteins; Risk; Thalidomide; Thrombopoietin | 2009 |
Acquired amegakaryocytic thrombocytopenia: potential role of thrombopoietin receptor agonists.
Topics: Benzoates; Bone Marrow Diseases; Humans; Hydrazines; Purpura, Thrombocytopenic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Salvage Therapy; Thrombopoietin | 2010 |
The therapy of lymphoma.
Topics: Adrenal Cortex Hormones; Asparaginase; Bone Marrow Diseases; Chlorambucil; Cyclophosphamide; Cytarabine; Daunorubicin; Fever; Humans; Hydrazines; Infections; Kidney Failure, Chronic; Lymphoma; Mechlorethamine; Splenectomy; Vinblastine; Vincristine | 1969 |
1 trial(s) available for hydrazine and Bone Marrow Diseases
| Article | Year |
|---|---|
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzoates; Blood Platelets; Bone Marrow Diseases; Chronic Disease; Female; Hematologic Neoplasms; Hemorrhage; Humans; Hydrazines; Liver Diseases; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin; Treatment Outcome; Young Adult | 2013 |
5 other study(ies) available for hydrazine and Bone Marrow Diseases
| Article | Year |
|---|---|
Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant.
Topics: Benzoates; Bone Marrow Diseases; Humans; Hydrazines; Immunoglobulins, Intravenous; Immunosuppressive Agents; Purpura, Thrombocytopenic; Pyrazoles; Thrombopoietin | 2022 |
Pembrolizumab-Induced Acquired Amegakaryocytic Thrombocytopenia and Successful Combination Treatment With Eltrombopag, Romiplostim and Cyclosporine: A Brief Communication.
Topics: Antibodies, Monoclonal, Humanized; Benzoates; Bone Marrow Diseases; Communication; Cyclosporine; Humans; Hydrazines; Purpura, Thrombocytopenic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Thrombopoietin | 2022 |
Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.
Topics: Adult; Aged; Antiphospholipid Syndrome; Benzoates; Bone Marrow Diseases; Drug Evaluation; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydrazines; Male; Middle Aged; Patient Selection; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Retrospective Studies; Salvage Therapy; Thrombocytopenia; Thrombopoiesis; Thrombopoietin | 2013 |
Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE).
Topics: Benzoates; Blood Platelets; Bone Marrow Diseases; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Megakaryocytes; Middle Aged; Molecular Mimicry; Purpura, Thrombocytopenic; Pyrazoles; Receptors, Thrombopoietin; Remission Induction; Treatment Outcome | 2010 |
PRELIMINARY CLINICAL RESULTS WITH A NEW ANTITUMOR AGENT RO 4-6467 (NSC-77213).
Topics: Antineoplastic Agents; Bone Marrow Diseases; Eosinophilia; Geriatrics; Hemolysis; Hodgkin Disease; Hydrazines; Leukemia; Leukemia, Lymphoid; Lymphocytosis; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Nausea; Neoplasms; Radiography, Thoracic; Toxicology; Vomiting | 1963 |